NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Abstract D-serine, an endogenous co-agonist at the glycine binding site of NMDA receptor NR1 subunits, is increasingly studied in Parkinson’s disease, where altered levels have been detected in both patients and animal models. Using a rat model based on α-synuclein overexpression, we evaluated renal effects after eight weeks of daily D-serine administration, alone or in combination with L-DOPA. Given the known acute nephrotoxicity of D-serine in rats, this study addresses the lack of data on chronic exposure. Our results show that a dose of 200 mg/kg induces biological alterations - reflected in growth patterns and water consumption - and peritubular inflammatory infiltrates comparable to the nephrotoxic effect reported after acute treatment. These findings suggest that 200 mg/kg could represent a threshold dose for chronic D-serine administration in rats, providing a useful reference for future studies involving prolonged treatment.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.